CLINICAL EVENTS CALENDAR
Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.
Current Issue
- Issue Number:3 (March 2010)
Q: What do you anticipate the CREST results will show?
Rosenfield: CREST (Carotid Revascularization Endarterectomy versus Stent Trial) is a landmark trial which shows that endarterectomy and stenting for carotid artery stenosis appear to be comparable based on the primary endpoint of the trial: death, stroke and myocardial infarction. Both carotid artery stenting (CAS) and carotid endarterectomy (CEA) had remarkably low event rates and were shown to be very safe and effective stroke prevention therapies. It should be noted that this is the largest (2,52
- Issue Number:3 (March 2010)
Introduction
Since the introduction of endovenous lasers (EVL) in the early 2000s, procedure methodologies, as well as device technologies, have evolved extensively in the endeavor to improve treatment outcomes. As each novel parameter has been studied, new data have enabled the venous ablation community to acquire an enhanced understanding of the laser’s mechanism of action. The primary subject matter in EVL studies has routinely included one or a combination of the following: laser fiber vein-wall contact,1,2 linear endovenous energy density (LEED),3,
- Issue Number:3 (March 2010)
Abstract
Persistent sciatic artery (PSA) is a rare congenital vascular anomaly that occurs when the sciatic artery fails to regress during fetal development. This failure to regress is often associated with superficial femoral artery (SFA) hypoplasia and the PSA then becomes the dominant arterial inflow to the lower limb. PSA is prone to several complications due to its anatomical course that exposes it to repeated trauma, with the most common complication being aneurysm formation. Here we describe the case of a 64-year-old female patient who presented with acute right low
- Issue Number:3 (March 2010)
Regardless of the merit of a new medical device, it does not take long for patients or relatives to inquire about new technology that could potentially be used to their advantage. However, when asked by an experienced and generally skeptical cardiology colleague who underwent aortic valve replacement with a bioprosthetic valve more than 10 years ago (with excellent results) whether a percutaneous valve may be an option for him in the event of prosthetic failure, two aspects of this new technique become apparent. First, it has already become a real treatment option and, second, spe - Issue Number:3 (March 2010)
Abstract
The Edwards-SAPIEN aortic valve (Edwards Lifesciences, Irvine, California) transapical approach was introduced into clinical practice in 2005. After feasibility studies, CE mark was obtained by the end of 2007. It is applied in operations on high-risk patients with calcific aortic valve stenosis, and allows for a less invasive replacement of the diseased native valve. Initially, patients were placed on cardiopulmonary bypass as a safety net, but improvements in periprocedural management soon allowed for truly off-pump implantation of these prostheses.
The fol - Issue Number:3 (March 2010)
Introduction
Transcatheter aortic valve implantation (TAVI) was first performed by Alain Cribier in 20021 using the balloon-expandable Cribier-Edwards valve. Soon after, the self-expandable CoreValve ReValving system (Medtronic, Inc., Minneapolis, Minnesota) was introduced based on a completely different design concept.2 Initial reports on safety and technical feasibility of these two new technologies raised expectations among interventional cardiologists,3–5 and both prostheses have undergone rapid development and implementation t
Vascular Disease Blogs
Robert S. Dieter, MD, RVT and Aravinda Nanjundappa, MD, RVT
Richard R. Heuser, MD, FACC, FACP, FESC, FASCI
VDM Monthly Poll
Digital Supplements
Terumo Clinical Case Update This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.
Vascular Disease News Wire
- Monday, March 1, 2010 - 22:25
- Sunday, February 28, 2010 - 20:53
- Friday, February 26, 2010 - 10:50
Anytown, California
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.
